Overview
Ebstein malformation of the tricuspid valve (also known as Ebstein anomaly or Ebstein's anomaly) is a rare congenital heart defect in which the tricuspid valve — the valve separating the right atrium from the right ventricle — is abnormally formed and displaced downward into the right ventricle. This displacement causes a portion of the right ventricle to become 'atrialized' (functionally part of the atrium), resulting in a smaller, less effective right ventricle and varying degrees of tricuspid valve regurgitation (leaking). The condition primarily affects the cardiovascular system and can be associated with an atrial septal defect or patent foramen ovale, which may allow right-to-left shunting of blood and lead to cyanosis (bluish discoloration of the skin due to low oxygen levels). The clinical presentation of Ebstein anomaly is highly variable, ranging from severe heart failure in neonates to mild symptoms discovered incidentally in adulthood. Key symptoms may include cyanosis, fatigue, exercise intolerance, shortness of breath, palpitations, and signs of right-sided heart failure such as peripheral edema and hepatomegaly. Cardiac arrhythmias are common, particularly supraventricular tachycardias, and some patients have accessory conduction pathways (Wolff-Parkinson-White syndrome). The condition is also associated with other congenital heart defects, including pulmonary stenosis or atresia. Management depends on the severity of the malformation. Mildly affected individuals may require only monitoring and medical management of arrhythmias and heart failure symptoms. More severely affected patients may require surgical intervention, including tricuspid valve repair (such as the cone reconstruction technique), tricuspid valve replacement, closure of atrial septal defects, or catheter ablation for arrhythmias. In the most severe neonatal cases, complex surgical strategies or even heart transplantation may be considered. Prognosis varies widely based on the degree of valve displacement and associated anomalies, but advances in surgical techniques have significantly improved outcomes for many patients.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Ebstein malformation of the tricuspid valve.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ebstein malformation of the tricuspid valve at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ebstein malformation of the tricuspid valve.
Community
No community posts yet. Be the first to share your experience with Ebstein malformation of the tricuspid valve.
Start the conversation →Latest news about Ebstein malformation of the tricuspid valve
No recent news articles for Ebstein malformation of the tricuspid valve.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ebstein malformation of the tricuspid valve
What is Ebstein malformation of the tricuspid valve?
Ebstein malformation of the tricuspid valve (also known as Ebstein anomaly or Ebstein's anomaly) is a rare congenital heart defect in which the tricuspid valve — the valve separating the right atrium from the right ventricle — is abnormally formed and displaced downward into the right ventricle. This displacement causes a portion of the right ventricle to become 'atrialized' (functionally part of the atrium), resulting in a smaller, less effective right ventricle and varying degrees of tricuspid valve regurgitation (leaking). The condition primarily affects the cardiovascular system and can be
Which specialists treat Ebstein malformation of the tricuspid valve?
2 specialists and care centers treating Ebstein malformation of the tricuspid valve are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.